Providing advanced molecular, genomic, and cellular technologies for cancer research
Molecular and cellular technologies form the basis for understanding cancer biology at high resolution. At UCCSH, a range of platforms enables comprehensive analyses of cells, genes, and molecular mechanisms across different cancer types.
These technologies support applications such as flow cytometry, molecular diagnostics, and high-throughput genomic analyses, including sequencing and single-cell approaches. Together, they contribute to the identification of biomarkers, disease mechanisms, and potential therapeutic targets.
FACS-Facility
Flow cytometry platforms at UCCSH provide advanced cell analysis and sorting technologies to support a wide range of biomedical and cancer research applications.
Immunology Kiel
Head: Dr. Christian Peters Peters (Christian.Peters@uksh.de) or Cytometry.corefacility@uksh.de
CANACORE (ISEF Lübeck)
Director: Prof. Dr. Jörg Köhl (joerg.koehl@uksh.de)
Hematology Laboratory Kiel – Section for Hematological Special Diagnostics
The Hematology Laboratory Kiel provides specialized diagnostic services for hematological malignancies, combining cytomorphology, molecular genetics, and flow cytometry to support clinical and translational research.
Head: Prof. Monika Brüggemann (Monika.Brueggemann@uksh.de)
Deputy Head: Prof. Christiane Pott (Christiane.Pott@uksh.de)
Cytomorphology
Contacts:
Dominique Wellnitz (Dominique.Wellnitz@uksh.de)
Lars Fransecky (Lars.Fransecky@uksh.de)
Molecular Genetics
Contacts:
Heiko Trautmann (Heiko.Trautmann@uksh.de)
Matthias Ritgen (Matthias.Ritgen@uksh.de)
Monika Brüggemann (Monika.Brueggemann@uksh.de)
Christiane Pott (Christiane.Pott@uksh.de)
Flow Cytometry
Contacts:
Matthias Ritgen (Matthias.Ritgen@uksh.de)
Monika Brüggemann (Monika.Brueggemann@uksh.de)
CCGA – Competence Centre for Genomic Analysis Kiel
The CCGA provides advanced genomic and sequencing technologies to support biomedical and cancer research, covering a wide range of high-throughput and multi-omics applications.
Genotyping
Microbiome Analysis
Head: PD Dr. Corinna Bang (c.bang@ikmb.uni-kiel.de)
Labor contact: microbiome-lab@ikmb.uni-kiel.de
Interdisciplinary Microbiome Platform
Head:
Dr. Mathilde Poyet (m.poyet@iem.uni-kiel.de)
Dr. Mathieu Groussin (m.groussin@ikmb.uni-kiel.de)
Sequencing Platform
Head (NGS Platform): Dr. Sören Franzenburg (s.franzenburg@ikmb.uni-kiel.de)
Single Cell Technologies Platform
Contact: Dr. Joana Pimenta Bernardes (j.pimentabernardes@ikmb.uni-kiel.de)
Spatial Transcriptomics Platform
Contact: Prof. Florian Tran (tran@ikmb.uni-kiel.de)
PROTAC Technology Platform
PROTAC-based approaches (Proteolysis Targeting Chimeras) represent an innovative strategy for targeted protein degradation and the development of novel therapeutic concepts in cancer research.
Approach: Targeted degradation of disease-relevant proteins via the ubiquitin–proteasome system
Application: Development of new therapeutic strategies for cancer and inflammatory diseases
Focus: Identification and validation of target proteins and development of PROTAC molecules
Research Unit Tumor Biochemistry
Website
Head: Prof. Dr. Elmar Wolf (elmar.wolf@biochem.uni-kiel.de)